98 related articles for article (PubMed ID: 27588378)
1. Periodontal conditions in juvenile idiopatic arthritis.
Maspero C; Giannini L; Galbiati G; Prevedello C; Farronato G
Minerva Stomatol; 2017 Apr; 66(2):43-50. PubMed ID: 27588378
[TBL] [Abstract][Full Text] [Related]
2. 90K immunostimulatory glycoprotein in children with juvenile idiopathic arthritis.
Cecamore C; Marsili M; Salvatore R; Troiani R; D'Egidio M; Tinari N; Pelliccia P; Chiarelli F; Marcovecchio ML; Breda L
Mod Rheumatol; 2018 Jul; 28(4):637-641. PubMed ID: 29157059
[TBL] [Abstract][Full Text] [Related]
3. Influence of etanercept on leptin and ghrelin secretion in children with juvenile idiopathic arthritis.
Maciejewska-Paszek I; Grochowska-Niedworok E; Siwiec A; Gruenpeter A; Dul L; Irzyniec T
J Int Med Res; 2017 Apr; 45(2):525-532. PubMed ID: 28415953
[TBL] [Abstract][Full Text] [Related]
4. Juvenile idiopathic arthritis activity and function ability: deleterious effects in periodontal disease?
Pugliese C; van der Vinne RT; Campos LM; Guardieiro PR; Saviolli C; Bonfá E; Pereira RM; Viana VS; Borba EF; Silva CA
Clin Rheumatol; 2016 Jan; 35(1):81-91. PubMed ID: 26626632
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
[TBL] [Abstract][Full Text] [Related]
6. Etanercept treatment for children with refractory juvenile idiopathic arthritis.
Kuo HC; Yu HR; Wu CC; Chang LS; Yang KD
J Microbiol Immunol Infect; 2011 Feb; 44(1):52-6. PubMed ID: 21531353
[TBL] [Abstract][Full Text] [Related]
7. The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.
Walters HM; Pan N; Lehman TJ; Adams A; Kalliolias GD; Zhu YS; Santiago F; Nguyen J; Sitaras L; Cunningham-Rundles S; Walsh TJ; Toussi SS
Clin Exp Immunol; 2016 Jun; 184(3):308-17. PubMed ID: 26934060
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the etanercept efficacy in children with juvenile idiopathic arthritis under the age of 4 years and children of older age groups using the propensity score matching method.
Alexeeva E; Dvoryakovskaya T; Denisova R; Sleptsova T; Isaeva K; Chomahidze A; Fetisova A; Mamutova A; Alshevskaya A; Gladkikh V; Moskalev A
Mod Rheumatol; 2019 Sep; 29(5):848-855. PubMed ID: 30149747
[No Abstract] [Full Text] [Related]
9. Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.
Verazza S; Davì S; Consolaro A; Bovis F; Insalaco A; Magni-Manzoni S; Nicolai R; Marafon DP; De Benedetti F; Gerloni V; Pontikaki I; Rovelli F; Cimaz R; Marino A; Zulian F; Martini G; Pastore S; Sandrin C; Corona F; Torcoletti M; Conti G; Fede C; Barone P; Cattalini M; Cortis E; Breda L; Olivieri AN; Civino A; Podda R; Rigante D; La Torre F; D'Angelo G; Jorini M; Gallizzi R; Maggio MC; Consolini R; De Fanti A; Muratore V; Alpigiani MG; Ruperto N; Martini A; Ravelli A;
Pediatr Rheumatol Online J; 2016 Dec; 14(1):68. PubMed ID: 27993144
[TBL] [Abstract][Full Text] [Related]
10. Periodontal conditions in patients with juvenile idiopathic arthritis.
Miranda LA; Fischer RG; Sztajnbok FR; Figueredo CM; Gustafsson A
J Clin Periodontol; 2003 Nov; 30(11):969-74. PubMed ID: 14761119
[TBL] [Abstract][Full Text] [Related]
11. Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
Kahn R; Berthold E; Gullstrand B; Schmidt T; Kahn F; Geborek P; Saxne T; Bengtsson AA; Månsson B
Acta Paediatr; 2016 Apr; 105(4):427-32. PubMed ID: 26707699
[TBL] [Abstract][Full Text] [Related]
12. Oral health and juvenile idiopathic arthritis: a review.
Walton AG; Welbury RR; Thomason JM; Foster HE
Rheumatology (Oxford); 2000 May; 39(5):550-5. PubMed ID: 10852988
[TBL] [Abstract][Full Text] [Related]
13. Dental plaque and gingival bleeding in adolescents with juvenile idiopathic arthritis and controls: a multilevel analysis.
Gil EG; Åstrøm AN; Lie SA; Rygg M; Fischer J; Rosén A; Bletsa A; Luukko K; Shi XQ; Halbig J; Frid P; Cetrelli L; Tylleskär K; Rosendahl K; Skeie MS
Acta Odontol Scand; 2023 Jan; 81(1):50-65. PubMed ID: 35635806
[TBL] [Abstract][Full Text] [Related]
14. Changes in periodontal and rheumatological conditions after 2 years in patients with juvenile idiopathic arthritis.
Miranda LA; Braga F; Fischer RG; Sztajnbok FR; Figueredo CM; Gustafsson A
J Periodontol; 2006 Oct; 77(10):1695-700. PubMed ID: 17032112
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.
Horneff G; Foeldvari I; Minden K; Trauzeddel R; Kümmerle-Deschner JB; Tenbrock K; Ganser G; Huppertz HI
Arthritis Rheumatol; 2015 May; 67(8):2240-9. PubMed ID: 25891010
[TBL] [Abstract][Full Text] [Related]
16. Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
Nimmrich S; Horneff G
Rheumatol Int; 2015 Mar; 35(3):465-70. PubMed ID: 25583050
[TBL] [Abstract][Full Text] [Related]
17. Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature.
Baldo F; Brena M; Carbogno S; Minoia F; Lanni S; Guez S; Petaccia A; Agostoni C; Cimaz R; Filocamo G
Pediatr Rheumatol Online J; 2021 Jun; 19(1):80. PubMed ID: 34082764
[TBL] [Abstract][Full Text] [Related]
18. Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.
Constantin T; Foeldvari I; Vojinovic J; Horneff G; Burgos-Vargas R; Nikishina I; Akikusa JD; Avcin T; Chaitow J; Koskova E; Lauwerys BR; Calvo Penades I; Flato B; Gamir ML; Huppertz HI; Jaller Raad JJ; Jarosova K; Anton J; Macku M; Otero Escalante WJ; Rutkowska-Sak L; Trauzeddel R; Velez-Sanchez PJ; Wouters C; Wajdula J; Zang C; Bukowski J; Woodworth D; Vlahos B; Martini A; Ruperto N;
J Rheumatol; 2016 Apr; 43(4):816-24. PubMed ID: 26932344
[TBL] [Abstract][Full Text] [Related]
19. Blueberry Improves the Therapeutic Effect of Etanercept on Patients with Juvenile Idiopathic Arthritis: Phase III Study.
Zhong Y; Wang Y; Guo J; Chu H; Gao Y; Pang L
Tohoku J Exp Med; 2015 Nov; 237(3):183-91. PubMed ID: 26477692
[TBL] [Abstract][Full Text] [Related]
20. Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan.
Hsin YC; Zhuang LZ; Yeh KW; Chang CW; Horng JT; Huang JL
PLoS One; 2015; 10(6):e0128768. PubMed ID: 26047099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
